OMB
.report
Search
0230 AER for Drugs SSA 2021 REV
0230 AER for Drugs SSA 2021 REV.docx
Postmarketing Adverse Drug Experience Reporting
OMB: 0910-0230
OMB.report
HHS/FDA
OMB 0910-0230
ICR 202303-0910-017
0230 AER for Drugs SSA 2021 REV
( Supporting Statement A )
Document [file]
Download:
file
|
pdf
File Type
inode/x-empty
© 2024 OMB.report |
Privacy Policy